Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.


TSXV:COV - Post by User

Bullboard Posts
Post by TheRock07on Aug 27, 2016 9:28am
128 Views
Post# 25183087

Covalent has 6.5 % of Saudi Wound care Device Market

Covalent has 6.5 % of Saudi Wound care Device Market

Covalon's new wound care products with the recent $11.1 million contracts now have 6.5 % of the Saudi Market ( 11.1/$170 million cad ).

Actually, with 3 other unspecified contracts, its higher than that
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
The major trend driving the wound care management devices is the increase in the number of Government initiatives towards the prevention of wounds and injuries and the technological advancements taking place simultaneously.

The Saudi Arabia wound care management devices Market is currently estimated to be valued as $0.134 billion for the year 2014 and is expected to reach $0.185 billion by the end of 2019. The CAGR during this period of forecast is 6.62%.

This escalation is developing the need to analyze, review and to forecast the growth of the wound care management device market. Owing to the rapid evolution of market in the use of wound closure devices, medical device companies which are able to launch new innovative equipment will be awarded with huge benefits.

Drivers

Increase in the aging population, rise in chronic wounds, ulcers and diabetes population, increase in the number of surgeries, rise in the number of government initiatives towards prevention of injuries and the rapid rise in the technological advancements are the major factors driving the growth of the wound care management device market.

 
Bullboard Posts